Nephros Company Top Insiders

Nephros Management Team Effectiveness

The company has return on total asset (ROA) of 0.0764 % which means that it generated a profit of $0.0764 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1629 %, meaning that it created $0.1629 on every $100 dollars invested by stockholders. Nephros' management efficiency ratios could be used to measure how well Nephros manages its routine affairs as well as how well it operates its assets and liabilities. The Nephros' current Return On Tangible Assets is estimated to increase to 0.01. The Nephros' current Return On Capital Employed is estimated to increase to 0.0006. As of now, Nephros' Return On Assets are increasing as compared to previous years. The Nephros' current Asset Turnover is estimated to increase to 1.19, while Total Assets are projected to decrease to under 7.7 M. The Nephros' current Common Stock Shares Outstanding is estimated to increase to about 12.8 M, while Net Loss is forecasted to increase to (6.3 M). The market capitalization of Nephros is $46.65 Million. 30% of Nephros outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run. Some institutional investors establish a significant position in stocks such as Nephros in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Nephros, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Nephros Workforce Comparison

The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Nephros Insider Trading History

Nephros Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Nephros often depends on how effective the management is. Nephros management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nephros management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nephros management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.